Janus Henderson Group
ADMA icon

Janus Henderson Group’s ADMA Biologics ADMA Stock Holding History

Janus Henderson Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$884K Sell
98,261
-3,838,158
-98% -$60.6M ﹤0.01% 1751
2025
Q4 		$71.8M Buy
3,936,419
+3,838,158
+3,906% +$64.7M 0.03% 347
2025
Q3 		$1.44M Sell
98,261
-189,408
-66% -$3.25M ﹤0.01% 1476
2025
Q2 		$5.24M Buy
287,669
+180,508
+168% +$3.68M ﹤0.01% 883
2025
Q1 		$2.17M Hold
107,161
– – ﹤0.01% 1238
2024
Q4 		$1.84M Buy
107,161
+15,000
+16% +$282K ﹤0.01% 1359
2024
Q3 		$1.84M Hold
92,161
– – ﹤0.01% 1343
2024
Q2 		$1.03M Sell
92,161
-1,122
-1% -$9.41K ﹤0.01% 1597
2024
Q1 		$615K Buy
93,283
+11
+0% +$60 ﹤0.01% 1912
2023
Q4 		$422K Sell
93,272
-147
-0.2% -$544 ﹤0.01% 2073
2023
Q3 		$334K Buy
93,419
+3
+0% +$12 ﹤0.01% 2141
2023
Q2 		$344K Sell
93,416
-86
-0.1% -$319 ﹤0.01% 2183
2023
Q1 		$309K Buy
93,502
+47,015
+101% +$163K ﹤0.01% 2271
2022
Q4 		$180K Buy
+46,487
New +$143K ﹤0.01% 2216

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janus Henderson Group's ADMA Position: Q1 2026 in Review

Janus Henderson Group reduced its ADMA Biologics (ADMA) stake by 98% in Q1 2026, selling an estimated $60.6M and leaving 98,261 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Janus Henderson Group first reported a position in ADMA in Q4 2022 and has held it in 14 quarters since. The position peaked at $71.8M in Q4 2025. 357 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Janus Henderson Group held 98,261 shares of ADMA Biologics worth $884K as of Q1 2026.
  • Janus Henderson Group sold 3,838,158 ADMA Biologics shares in Q1 2026, an estimated $60.6M.
  • ADMA Biologics made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1751 holding.
  • Janus Henderson Group first reported a position in ADMA Biologics in Q4 2022 and has held it in 14 quarters since.
  • Janus Henderson Group's ADMA Biologics position peaked at $71.8M in Q4 2025.
  • 357 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.